These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23958262)

  • 1. Fibrate therapy and circulating adiponectin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials.
    Sahebkar A; Watts GF
    Atherosclerosis; 2013 Sep; 230(1):110-20. PubMed ID: 23958262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head-to-head comparison of fibrates versus statins for elevation of circulating adiponectin concentrations: a systematic review and meta-analysis.
    Sahebkar A
    Metabolism; 2013 Dec; 62(12):1876-85. PubMed ID: 24095632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrate therapy and flow-mediated dilation: A systematic review and meta-analysis of randomized placebo-controlled trials.
    Sahebkar A; Giua R; Pedone C; Ray KK; Vallejo-Vaz AJ; Costanzo L
    Pharmacol Res; 2016 Sep; 111():163-179. PubMed ID: 27320045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of fibrate therapy on plasma plasminogen activator inhibitor-1: a systematic review and meta-analysis of randomized controlled trials.
    Sahebkar A; Simental-Mendía LE; Watts GF; Golledge J
    Atherosclerosis; 2015 May; 240(1):284-96. PubMed ID: 25828270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of proprotein convertase subtilisin kexin type 9 are elevated by fibrate therapy: a systematic review and meta-analysis of clinical trials.
    Sahebkar A
    Cardiol Rev; 2014; 22(6):306-12. PubMed ID: 24614537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do persons with diabetes benefit from combination statin and fibrate therapy?
    Rosenblit PD
    Curr Cardiol Rep; 2012 Feb; 14(1):112-24. PubMed ID: 22213157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: a meta-analysis.
    Lee M; Saver JL; Towfighi A; Chow J; Ovbiagele B
    Atherosclerosis; 2011 Aug; 217(2):492-8. PubMed ID: 21592479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of fibrates on lowering low-density lipoprotein cholesterol and cardiovascular risk reduction: a systemic review and meta-analysis.
    Kim KA; Kim NJ; Choo EH
    Eur J Prev Cardiol; 2024 Feb; 31(3):291-301. PubMed ID: 37855457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Fibrate Treatment on Circulating Adipokine Levels: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
    Simental-Mendía LE; Simental-Mendía M; Sahebkar A; Atkin SL; Jamialahmadi T
    Arch Med Res; 2024 Feb; 55(2):102957. PubMed ID: 38266418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma uric acid concentrations are reduced by fenofibrate: A systematic review and meta-analysis of randomized placebo-controlled trials.
    Derosa G; Maffioli P; Sahebkar A
    Pharmacol Res; 2015 Dec; 102():63-70. PubMed ID: 26384444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fish oil on circulating adiponectin: a systematic review and meta-analysis of randomized controlled trials.
    Wu JH; Cahill LE; Mozaffarian D
    J Clin Endocrinol Metab; 2013 Jun; 98(6):2451-9. PubMed ID: 23703724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of pemafibrate administration in patients with dyslipidemia: a systematic review and meta-analysis.
    Ida S; Kaneko R; Murata K
    Cardiovasc Diabetol; 2019 Mar; 18(1):38. PubMed ID: 30898163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of fibrates on circulating cystatin C levels: a systematic review and meta-analysis of clinical trials.
    Sahebkar A; Simental-Mendía LE; Pirro M; Montecucco F; Carbone F; Banach M; Barreto GE; Butler AE
    Ann Med; 2018 Sep; 50(6):485-493. PubMed ID: 29957074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fibrates on glycemic parameters: A systematic review and meta-analysis of randomized placebo-controlled trials.
    Simental-Mendía LE; Simental-Mendía M; Sánchez-García A; Banach M; Atkin SL; Gotto AM; Sahebkar A
    Pharmacol Res; 2018 Jun; 132():232-241. PubMed ID: 29292213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Dipeptidyl Peptidase-4 Inhibitors on Plasma Adiponectin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Sahebkar A; Ponzo V; Bo S
    Curr Med Chem; 2016; 23(13):1356-69. PubMed ID: 27048342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials.
    Sahebkar A; Simental-Mendía LE; Katsiki N; Reiner Ž; Banach M; Pirro M; Atkin SL
    BMJ Open; 2019 Feb; 8(11):e021508. PubMed ID: 30798284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of fibrates and cancer risk: a systematic review and meta-analysis of 17 long-term randomized placebo-controlled trials.
    Bonovas S; Nikolopoulos GK; Bagos PG
    PLoS One; 2012; 7(9):e45259. PubMed ID: 23028888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials.
    Nissen SE; Nicholls SJ; Wolski K; Howey DC; McErlean E; Wang MD; Gomez EV; Russo JM
    JAMA; 2007 Mar; 297(12):1362-73. PubMed ID: 17384435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of fibrate-statin combination therapy compared to fibrate monotherapy in patients with dyslipidemia: a meta-analysis.
    Choi HD; Shin WG; Lee JY; Kang BC
    Vascul Pharmacol; 2015; 65-66():23-30. PubMed ID: 25451563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.